武汉久安药物研究院

Wuhan Jiu'an Pharmaceutical Research Institute is a specialized drug research and development organization based in Wuhan, China, serving as a core R&D subsidiary for the Humanwell Healthcare Group. The institute focuses on the development of innovative small molecule therapeutics and high-end generic drugs, particularly in the fields of anesthesiology, analgesia, and central nervous system (CNS) disorders. Its technical capabilities encompass the entire drug development process, including chemical synthesis, formulation research, pharmaceutical analysis, and clinical trial management. By maintaining a robust quality management system and advanced analytical platforms, the institute supports Humanwell's global strategy through consistency evaluations and the advancement of a diverse pipeline of value-added medicines.